109 related articles for article (PubMed ID: 18417193)
1. Enhancing effect of the (145)Met-allele of GPIb alpha on platelet sensitivity to aspirin under high-shear conditions.
Matsubara Y; Murata M; Watanabe G; Ikeda Y
Thromb Res; 2008; 123(2):331-5. PubMed ID: 18417193
[No Abstract] [Full Text] [Related]
2. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
3. Biomedicine. Contact--how platelets touch von Willebrand factor.
Sadler JE
Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
[No Abstract] [Full Text] [Related]
4. A second report of platelet-type von Willebrand disease with a Gly233Ser mutation in the GPIBA gene.
Nurden P; Lanza F; Bonnafous-Faurie C; Nurden A
Thromb Haemost; 2007 Feb; 97(2):319-21. PubMed ID: 17264965
[No Abstract] [Full Text] [Related]
5. Association between platelet glycoprotein Ib-alpha and myocardial infarction: results of a pilot study performed in male and female patients from Sicily.
Candore G; Piazza G; Crivello A; Grimaldi MP; Orlando V; Caruso M; Caimi G; Hoffmann E; Incalcaterra E; Lio D; Caruso C
Ann N Y Acad Sci; 2006 Nov; 1089():502-8. PubMed ID: 17261793
[TBL] [Abstract][Full Text] [Related]
6. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
7. [Involvement of platelet collagen receptors in primary hemostasis].
Kralisz U; Stasiak M
Postepy Biochem; 2007; 53(4):344-55. PubMed ID: 19024899
[TBL] [Abstract][Full Text] [Related]
8. [The molecular mechanisms of platelets activation in patients with cerebrovascular disease].
Sirotkina OV; Laskovets AB; Goldobin VV; Topanova AA; Karelov DV; Vavilova TV
Biomed Khim; 2015; 61(5):606-12. PubMed ID: 26539867
[TBL] [Abstract][Full Text] [Related]
9. A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation.
McNicol A; Eyer E; Jackson EC; Israels SJ
Thromb Haemost; 2007 Dec; 98(6):1382-4. PubMed ID: 18064343
[No Abstract] [Full Text] [Related]
10. Simulation of platelet adhesion and aggregation regulated by fibrinogen and von Willebrand factor.
Mori D; Yano K; Tsubota K; Ishikawa T; Wada S; Yamaguchi T
Thromb Haemost; 2008 Jan; 99(1):108-15. PubMed ID: 18217141
[TBL] [Abstract][Full Text] [Related]
11. Platelet GPIb complex as a target for anti-thrombotic drug development.
Clemetson KJ; Clemetson JM
Thromb Haemost; 2008 Mar; 99(3):473-9. PubMed ID: 18327394
[TBL] [Abstract][Full Text] [Related]
12. Platelet function and arterial thrombosis.
Ruggeri ZM; Landolfi R
Ital Heart J; 2001 Nov; 2(11):809-10. PubMed ID: 11770863
[No Abstract] [Full Text] [Related]
13. Variable number of tandem repeats polymorphism of platelet glycoprotein Ib alpha in Chinese people and CC genotype with aspirin sensitivity in patients with cerebral infarction.
Jin YY; Yu GZ; Wang Y; Cui LY; Xin XM
J Clin Pharm Ther; 2009 Apr; 34(2):239-43. PubMed ID: 19250145
[TBL] [Abstract][Full Text] [Related]
14. Platelet GPIb: sensing force and responding.
Ruggeri ZM
Blood; 2015 Jan; 125(3):423-4. PubMed ID: 25593332
[TBL] [Abstract][Full Text] [Related]
15. Shear induces a unique series of morphological changes in translocating platelets: effects of morphology on translocation dynamics.
Maxwell MJ; Dopheide SM; Turner SJ; Jackson SP
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):663-9. PubMed ID: 16385083
[TBL] [Abstract][Full Text] [Related]
16. Platelet glycoprotein Ibalpha polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic disease.
Jilma-Stohlawetz P; Jilma B; Mannhalter C; Bencur P; Pabinger I; Vormittag R; Dunkler D; Panzer S
Ann Hematol; 2007 Oct; 86(10):719-25. PubMed ID: 17634946
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective α-granule secretion.
Langer F; Obser T; Oyen F; Spath B; Holstein K; Greinacher A; White JG; Budde U; Bokemeyer C; Schneppenheim R
Thromb Haemost; 2014 Apr; 111(4):777-9. PubMed ID: 24337418
[No Abstract] [Full Text] [Related]
18. Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist.
Berny MA; White TC; Tucker EI; Bush-Pelc LA; Di Cera E; Gruber A; McCarty OJ
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):329-34. PubMed ID: 17962622
[TBL] [Abstract][Full Text] [Related]
19. Thrombin formation in vitro in response to shear-induced activation of platelets.
Fallon AM; Marzec UM; Hanson SR; Yoganathan AP
Thromb Res; 2007; 121(3):397-406. PubMed ID: 17532367
[TBL] [Abstract][Full Text] [Related]
20. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.
Franchini M; Montagnana M; Lippi G
Int J Lab Hematol; 2008 Apr; 30(2):91-4. PubMed ID: 18333841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
